Last 7 days
-0.1%
Last 30 days
5.1%
Last 90 days
4.8%
Trailing 12 Months
8.5%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-14 | Chambers Michael Andrew | bought | 1,092,430 | 109 | 9,979 | - |
2023-08-11 | Chambers Michael Andrew | bought | 2,559,270 | 108 | 23,686 | - |
2023-08-10 | Chambers Michael Andrew | bought | 3,701,070 | 106 | 34,867 | - |
2023-08-04 | Wigzell Hans Lennart Rudolf | acquired | 435,450 | 29.03 | 15,000 | - |
2023-08-04 | Wigzell Hans Lennart Rudolf | sold | -1,600,800 | 106 | -15,000 | - |
2023-06-01 | Brown Ryan Edward | sold (taxes) | -11,000 | 123 | -89.00 | evp, general counsel |
2023-03-30 | Arif Bilal | sold (taxes) | -41,954 | 136 | -307 | chief tech ops officer |
2023-03-08 | Rodino-Klapac Louise | sold (taxes) | -139,709 | 153 | -912 | head of r&d, cso |
2023-03-08 | Arif Bilal | sold (taxes) | -48,101 | 153 | -314 | chief tech ops officer |
2023-03-08 | Brown Ryan Edward | sold (taxes) | -97,275 | 153 | -635 | svp, general counsel |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-13 | CGC Financial Services, LLC | new | - | 104,557 | 104,557 | 0.07% |
2023-09-12 | Farther Finance Advisors, LLC | unchanged | - | -443 | 2,176 | -% |
2023-08-29 | EFG Asset Management (Americas) Corp. | added | 16.23 | -8,219 | 231,330 | 0.05% |
2023-08-25 | Yarbrough Capital, LLC | new | - | 319,511 | 319,511 | 0.02% |
2023-08-24 | PERCEPTIVE ADVISORS LLC | reduced | -68.92 | -26,669,500 | 9,284,590 | 0.27% |
2023-08-23 | WOLVERINE TRADING, LLC | reduced | -71.17 | -3,338,190 | 1,041,810 | -% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | reduced | -34.78 | -1,016,600 | 1,202,460 | 0.01% |
2023-08-22 | Asset Dedication, LLC | unchanged | - | -12,000 | 57,000 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -16.52 | -1,041,320 | 2,357,610 | -% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | added | 44.27 | 377,000 | 2,272,000 | 0.02% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | sands capital management, llc | 2.5% | 2,151,378 | SC 13G/A | |
Feb 10, 2023 | janus henderson group plc | 6.9% | 6,028,016 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.15% | 8,033,264 | SC 13G/A | |
Feb 01, 2023 | blackrock inc. | 6.3% | 5,557,234 | SC 13G/A | |
Feb 14, 2022 | sands capital management, llc | 6.16% | 5,364,627 | SC 13G | |
Feb 11, 2022 | janus henderson group plc | 8.3% | 7,245,862 | SC 13G | |
Feb 10, 2022 | vanguard group inc | 9.54% | 8,311,108 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 6.1% | 5,285,234 | SC 13G/A | |
Aug 10, 2021 | capital research global investors | 4.8% | 3,842,491 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Aug 15, 2023 | 4 | Insider Trading | |
Aug 14, 2023 | 4 | Insider Trading | |
Aug 11, 2023 | 4 | Insider Trading | |
Aug 08, 2023 | 4 | Insider Trading | |
Aug 04, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 02, 2023 | S-8 | Employee Benefits Plan | |
Aug 02, 2023 | 10-Q | Quarterly Report | |
Jun 22, 2023 | 8-K | Current Report | |
Jun 22, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABBV | 271.1B | 56.0B | 3.50% | 10.46% | 31.22 | 4.84 | -2.31% | -31.27% |
BGNE | 258.4B | 1.8B | -3.35% | 26.15% | -149.17 | 142.72 | 69.45% | 14.65% |
VRTX | 91.3B | 9.5B | 1.11% | 26.35% | 27.14 | 9.61 | 13.83% | 5.33% |
REGN | 88.1B | 12.7B | -2.05% | 20.27% | 20.49 | 6.95 | -10.94% | -24.40% |
ALNY | 21.7B | 1.2B | -8.20% | -15.77% | -20.42 | 17.55 | 39.94% | -8.44% |
SRPT | 11.2B | 1.0B | 5.15% | 8.54% | -12.29 | 11.11 | 20.15% | -79.16% |
UTHR | 10.5B | 2.1B | -3.19% | 8.81% | 12.04 | 4.97 | 18.01% | 38.16% |
MID-CAP | ||||||||
BPMC | 3.0B | 225.6M | 0.06% | -27.49% | -5.4 | 13.27 | -2.11% | 21.02% |
MDGL | 2.9B | - | -11.82% | 158.82% | -8.93 | - | - | -28.88% |
RARE | 2.6B | 402.9M | 1.47% | -16.95% | -3.63 | 6.49 | 20.50% | -42.46% |
MRTX | 2.1B | 27.2M | -3.08% | -49.09% | -2.89 | 78.22 | - | -14.43% |
SMALL-CAP | ||||||||
CYTK | 3.1B | - | -6.35% | -39.40% | -7.31 | 33.28 | 34.30% | -149.91% |
CPRX | 1.3B | 302.9M | -15.88% | -2.65% | 11.18 | 4.26 | 77.72% | 112.02% |
MGNX | 289.9M | 152.5M | -10.34% | 48.10% | 38.91 | 1.9 | 127.84% | 103.41% |
CRBP | 28.7M | - | 0.62% | 3389.00% | -0.62 | - | - | -31.51% |
9.6%
10.1%
-4.1%
-5.8%
99.2%
85.8%
39.2%
Y-axis is the maximum loss one would have experienced if Sarepta Therapeutics was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 2.8% | 1,003,434,000 | 975,683,000 | 933,013,000 | 876,047,000 | 835,184,000 | 765,786,000 | 701,887,000 | 645,564,000 | 600,082,000 | 573,356,000 | 540,099,000 | 495,074,000 | 450,191,000 | 407,496,000 | 380,833,000 | 365,135,000 | 344,580,000 | 323,441,000 | 301,034,000 | 273,896,000 | 241,364,000 |
Costs and Expenses | -3.2% | 1,513,229,000 | 1,563,091,000 | 1,469,214,000 | 1,411,228,000 | 1,273,468,000 | 1,160,512,000 | 1,161,597,000 | 1,170,177,000 | 1,227,305,000 | 1,171,358,000 | 1,104,262,000 | 1,118,740,000 | 1,060,379,000 | 1,154,698,000 | 1,086,396,000 | 979,842,000 | 905,796,000 | 712,717,000 | 644,662,000 | 501,308,000 | 444,584,000 |
S&GA Expenses | -7.3% | 454,543,000 | 490,295,000 | 451,421,000 | 408,998,000 | 365,338,000 | 283,369,000 | 282,660,000 | 290,651,000 | 304,897,000 | 306,238,000 | 317,875,000 | 313,253,000 | 313,309,000 | 307,014,000 | 284,812,000 | 267,608,000 | 245,223,000 | 224,986,000 | 207,761,000 | 175,762,000 | 150,894,000 |
R&D Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 436,610,000 | 446,192,000 | 401,843,000 | 300,077,000 | 247,732,000 |
EBITDA | 100.0% | - | -1,016,324,000 | -603,681,000 | -611,595,000 | -404,838,000 | -252,225,000 | -317,406,000 | -384,177,000 | -538,655,000 | -611,786,000 | -466,207,000 | -517,648,000 | -453,595,000 | -585,552,000 | -652,664,000 | - | - | - | - | - | - |
EBITDA Margin | 100.0% | - | -1.04 | -0.65 | -0.70 | -0.48 | -0.33 | -0.45 | -0.60 | -0.90 | -1.07 | -0.86 | -1.05 | -1.01 | -1.44 | -1.71 | - | - | - | - | - | - |
Interest Expenses | -38.5% | 24,455,000 | 39,753,000 | 44,418,000 | 57,495,000 | 55,949,000 | 55,949,000 | 55,949,000 | 53,683,000 | 47,166,000 | 40,721,000 | 34,418,000 | 24,737,000 | 19,307,000 | 12,880,000 | 8,550,000 | 8,894,000 | 10,500,000 | - | 11,308,000 | 7,849,000 | 7,432,000 |
Earnings Before Taxes | 19.4% | -885,019,000 | -1,098,527,000 | -689,963,000 | -710,546,000 | -502,035,000 | -355,701,000 | -418,948,000 | -485,544,000 | -634,040,000 | -703,081,000 | -553,065,000 | -599,572,000 | -529,269,000 | -654,698,000 | -713,880,000 | -620,562,000 | -571,529,000 | -403,945,000 | -362,610,000 | -246,776,000 | -215,432,000 |
EBT Margin | 100.0% | - | -1.13 | -0.74 | -0.81 | -0.60 | -0.46 | -0.60 | -0.75 | -1.06 | -1.23 | -1.02 | -1.21 | -1.18 | -1.61 | -1.87 | - | - | - | - | - | - |
Net Income | 18.6% | -907,677,000 | -1,115,218,000 | -703,488,000 | -716,225,000 | -506,631,000 | -356,555,000 | -418,780,000 | -486,116,000 | -634,471,000 | -703,886,000 | -554,128,000 | -600,514,000 | -530,341,000 | -655,924,000 | -715,075,000 | -620,267,000 | -570,334,000 | -403,198,000 | -361,918,000 | -245,021,000 | -216,362,000 |
Net Income Margin | 100.0% | - | -1.14 | -0.75 | -0.82 | -0.61 | -0.47 | -0.60 | -0.75 | -1.06 | -1.23 | -1.03 | -1.21 | -1.18 | -1.61 | -1.88 | - | - | - | - | - | - |
Free Cashflow | 100.0% | - | -468,325,000 | -356,170,000 | -287,346,000 | -347,721,000 | -386,868,000 | -481,662,000 | -653,275,000 | -783,194,000 | -794,926,000 | 25,264,000 | 47,357,000 | 233,986,000 | 265,072,000 | -516,094,000 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 2.2% | 3,126 | 3,060 | 3,128 | 3,156 | 2,997 | 3,056 | 3,148 | 2,662 | 2,759 | 2,765 | 2,985 | 2,781 | 2,883 | 2,947 | 1,823 | 1,702 | 1,748 | 1,964 | 1,642 | 1,183 | 1,247 |
Current Assets | -0.6% | 2,473 | 2,488 | 2,558 | 2,626 | 2,469 | 2,531 | 2,604 | 2,185 | 2,265 | 2,271 | 2,485 | 2,323 | 2,459 | 2,547 | 1,469 | 1,362 | 1,427 | 1,671 | 1,426 | 1,012 | 1,139 |
Cash Equivalents | -2.3% | 852 | 872 | 967 | 1,039 | 869 | 1,234 | 2,116 | 1,599 | 1,697 | 1,482 | 1,503 | 1,475 | 1,640 | 1,764 | 835 | 725 | 809 | 732 | 371 | 210 | 410 |
Inventory | 11.9% | 227 | 203 | 204 | 221 | 208 | 199 | 186 | 288 | 269 | 240 | 232 | 220 | 180 | 173 | 171 | 166 | 157 | 140 | 125 | 116 | 104 |
Net PPE | 3.3% | 189 | 183 | 180 | 181 | 183 | 187 | 191 | 199 | 203 | 203 | 190 | 172 | 153 | 137 | 130 | 120 | 117 | 106 | 97.00 | 77.00 | 58.00 |
Liabilities | 1.6% | 2,384 | 2,347 | 2,743 | 2,725 | 2,270 | 2,199 | 2,220 | 2,193 | 2,274 | 2,230 | 2,223 | 1,889 | 1,840 | 1,803 | 1,005 | 707 | 649 | 615 | 610 | 543 | 548 |
Current Liabilities | -7.1% | 499 | 537 | 620 | 603 | 546 | 455 | 453 | 373 | 425 | 365 | 416 | 378 | 355 | 306 | 265 | 216 | 162 | 137 | 174 | 114 | 105 |
Shareholder's Equity | 4.0% | 741 | 713 | 385 | 431 | 726 | 857 | 928 | 470 | 485 | 535 | 762 | 892 | 1,043 | 1,145 | 818 | 995 | 1,099 | 1,349 | 1,032 | 640 | 699 |
Retained Earnings | -0.5% | -4,450 | -4,426 | -3,910 | -3,800 | -3,543 | -3,311 | -3,206 | -3,084 | -3,036 | -2,955 | -2,848 | -2,658 | -2,462 | -2,311 | -2,294 | -2,058 | -1,931 | -1,655 | -1,578 | -1,438 | -1,361 |
Additional Paid-In Capital | 1.0% | 5,193 | 5,140 | 4,297 | 4,235 | 4,272 | 4,169 | 4,135 | 3,554 | 3,522 | 3,491 | 3,610 | 3,551 | 3,505 | 3,456 | 3,112 | 3,053 | 3,031 | 3,004 | 2,611 | 2,078 | 2,061 |
Accumulated Depreciation | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 45.00 | 38.00 | 33.00 | 28.00 | 25.00 | 22.00 |
Shares Outstanding | 0.1% | 93.00 | 93.00 | 88.00 | 88.00 | 88.00 | 87.00 | 87.00 | 80.00 | 80.00 | 80.00 | 79.00 | 79.00 | 77.00 | 76.00 | 74.00 | 75.00 | 74.00 | 74.00 | 66.00 | 67.00 | 66.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -12.8% | -488 | -433 | -325 | -262 | -321 | -363 | -443 | -588 | -702 | -700 | 107 | 118 | 289 | 318 | -456 | -415 | -460 | -499 | -388 | -297 | -241 |
Share Based Compensation | -22.7% | 190 | 245 | 233 | 212 | 189 | 115 | 114 | 114 | 114 | 113 | 108 | 101 | 94.00 | 86.00 | 79.00 | 69.00 | 60.00 | 56.00 | 50.00 | 45.00 | 40.00 |
Cashflow From Investing | 155.5% | 138 | -248 | -1,046 | -1,059 | -1,058 | -447 | 495 | 374 | 408 | 53.00 | -121 | 19.00 | -52.78 | 134 | 287 | 32.00 | -13.53 | -221 | -370 | -626 | -438 |
Cashflow From Financing | 1.7% | 335 | 329 | 233 | 771 | 560 | 564 | 562 | 339 | 352 | 366 | 682 | 612 | 595 | 584 | 643 | 907 | 881 | 900 | 530 | 516 | 922 |
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenues: | ||||
Products, net | $ 238,988 | $ 211,237 | $ 470,483 | $ 400,062 |
Type of Revenue [Extensible List] | us-gaap:ProductMember | us-gaap:ProductMember | ||
Collaboration | 22,250 | 22,250 | $ 44,255 | $ 44,255 |
Total revenues | 261,238 | 233,487 | 514,738 | 444,317 |
Cost and expenses: | ||||
Cost of sales (excluding amortization of in-licensed rights) | 34,124 | 37,795 | 69,141 | 69,238 |
Research and development | 241,890 | 252,329 | 487,569 | 446,579 |
Selling, general and administrative | 118,564 | 154,316 | 229,278 | 226,156 |
Amortization of in-licensed rights | 179 | 179 | 357 | 357 |
Total cost and expenses | 394,757 | 444,619 | 786,345 | 742,330 |
Operating loss | (133,519) | (211,132) | (271,607) | (298,013) |
Other loss, net: | ||||
Gain from sale of Priority Review Voucher | 102,000 | 0 | 102,000 | 0 |
Loss on debt extinguishment | 0 | 0 | (387,329) | 0 |
Other income (expense), net | 16,934 | (16,961) | 29,641 | (34,226) |
Total other (loss), net | 118,934 | (16,961) | (255,688) | (34,226) |
Loss before income tax expense (benefit) | (14,585) | (228,093) | (527,295) | (332,239) |
Income tax expense (benefit) | 9,355 | 3,388 | 13,400 | 4,267 |
Net loss | (23,940) | (231,481) | (540,695) | (336,506) |
Other comprehensive income (loss): | ||||
Unrealized gains (losses) on investments, net of tax | (636) | (2,179) | 609 | (2,465) |
Total other comprehensive income (loss) | (636) | (2,179) | 609 | (2,465) |
Comprehensive loss | $ (24,576) | $ (233,660) | $ (540,086) | $ (338,971) |
Net loss per share - basic | $ (0.27) | $ (2.65) | $ (6.11) | $ (3.85) |
Net loss per share - diluted | $ (0.27) | $ (2.65) | $ (6.11) | $ (3.85) |
Weighted average number of shares of common stock used in computing basic and diluted net loss per share | 88,743 | 87,511 | 88,466 | 87,383 |
Weighted average number of shares of common stock used in computing basic and diluted net loss per share | 88,743 | 87,511 | 88,466 | 87,383 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 851,929 | $ 966,777 |
Short-term investments | 1,008,786 | 1,022,597 |
Accounts receivable | 236,808 | 214,628 |
Inventory | 226,876 | 203,968 |
Other current assets | 148,215 | 149,891 |
Total current assets | 2,472,614 | 2,557,861 |
Property and equipment, net | 188,874 | 180,037 |
Right of use assets | 134,728 | 64,954 |
Non-current inventory | 166,635 | 162,545 |
Other non-current assets | 163,039 | 162,969 |
Total assets | 3,125,890 | 3,128,366 |
Current liabilities: | ||
Accounts payable | 109,796 | 95,875 |
Accrued expenses | 326,877 | 418,996 |
Deferred revenue, current portion | 44,989 | 89,244 |
Other current liabilities | 16,992 | 15,489 |
Total current liabilities | 498,654 | 619,604 |
Long-term debt | 1,235,517 | 1,544,292 |
Lease liabilities, net of current portion | 129,170 | 57,578 |
Deferred revenue, net of current portion | 485,000 | 485,000 |
Contingent consideration | 36,100 | 36,900 |
Other non-current liabilities | 38 | 42 |
Total liabilities | 2,384,479 | 2,743,416 |
Commitments and contingencies (Note 16) | ||
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value, 3,333,333 shares authorized; none issued and outstanding | 0 | 0 |
Common stock, $0.0001 par value, 198,000,000 shares authorized; 93,273,541 and 87,950,117 issued and outstanding at June 30, 2023, and December 31, 2022, respectively | 9 | 9 |
Additional paid-in capital | 5,193,388 | 4,296,841 |
Accumulated other comprehensive loss, net of tax | (1,055) | (1,664) |
Accumulated deficit | (4,450,931) | (3,910,236) |
Total stockholders’ equity | 741,411 | 384,950 |
Total liabilities and stockholders’ equity | $ 3,125,890 | $ 3,128,366 |